Anika Therapeutics | ANIK - Zobowiązania Handlowe





Zobowiązania Handlowe Zmiana Data
Abbott USD 4.24B 117M 2025-12
Agenus USD 71.08M 11.9M 2026-03
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
Anika Therapeutics USD 6.34M 298K 2026-03
Arrowhead Research USD 30.75M 2.19M 2026-03
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
Halozyme Therapeutics USD 14.1M 6.8M 2026-03
Heron Therapeutics USD 8.97M 24K 2026-03
Insmed USD 73.38M 6.53M 2026-03
Integra LifeSciences USD 87.95M 7.78M 2026-03
Intrexon USD 4.85M 3.12M 2024-06
J&J USD 10.46B 1.53B 2026-03
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Ligand Pharmaceuticals USD 37.11M 33.87M 2026-03
MacroGenics USD 4.29M 500K 2026-03
Merit Medical Systems USD 67.85M 7.3M 2026-03
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 22.71B 219M 2026-03
Smith & Nephew USD 1.19B 73M 2025-12
Stryker USD 1.8B 301M 2025-12
Veracyte USD 6.91M 2.32M 2026-03
Xencor USD 7.92M 2.91M 2026-03
Zimmer Biomet Holdings USD 361.2M 58.2M 2026-03